fda statement bpc-157 not approved safety warning Wolverine Stack: Healing Faster with Peptides FDA is moving to restrict
Description
Candidates for Quad-mix injections: Patients who have failed on trimix, oral ED tablets, have low testosterone, diabetes, prostate issues, neurological/spinal injury, and prostate cancer
The stakes are high on both sides: for patients who depend on these treatments, and for providers who face potential enforcement risk if they continue prescribing compounds that ultimately are not approved for the 503A Bulks List
It's a formidable opponent to progress
Everyone here is great
